Fundraising Fox
/Companies
Sign in

Mirata Pharmaceuticals

Plymouth Meeting, US · Founded 2016 · 1 known investors

Find your way into Mirata Pharmaceuticals

Sign up to find every way you can get introduced to Mirata Pharmaceuticals

  • Your email: who you already know at Mirata Pharmaceuticals, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Mirata Pharmaceuticals team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Mirata Pharmaceuticals is developing pain-relieving drugs intended to provide the analgesic benefits of opioids without their addictive properties and serious side effects. It targets patients and physicians seeking safer alternatives to prescription opioids.

BiotechHealthtech

Founders & leadership

JJ
John JohnsonNamed on SEC filing
BH
Brian HubbardNamed on SEC filing
JY
Jason Y ZhangNamed on SEC filing
MG
Maurits GeerlingsNamed on SEC filing
MC
Matthew CallahanNamed on SEC filing

Board

JF
Joseph F LovettBoard directorManaging Director at Louisiana Funds

Investors · 1

Reported raises · per SEC filings

Form D private placements

$7.1M disclosed across 1 round · 2018

▶$7.1MraisedJan 2019 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John JohnsonDirector
  • Joseph F LovettDirector
  • Brian HubbardDirector
  • Jason Y ZhangDirector
  • Maurits GeerlingsDirector
  • Matthew CallahanExecutive Officer, Director
Offering amount
$8M
Amount sold
$7.1M
Proceeds to insiders
$12.7K
First sale
Jun 2018
Incorporated
Limited Liability Company, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Mirata Pharmaceuticals do?
Mirata Pharmaceuticals is developing pain-relieving drugs intended to provide the analgesic benefits of opioids without their addictive properties and serious side effects. It targets patients and physicians seeking safer alternatives to prescription opioids.
Who are Mirata Pharmaceuticals's investors?
Mirata Pharmaceuticals's investors include Louisiana Funds.
How much funding has Mirata Pharmaceuticals raised?
Mirata Pharmaceuticals has disclosed $7.1M raised across 1 round.
Where is Mirata Pharmaceuticals headquartered?
Mirata Pharmaceuticals is headquartered in Plymouth Meeting, US.